BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Pharm Country

  9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To

  Pfizer may be the surprise strong-growth stock for next year.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Bay

  3 Hot Cancer Immunotherapies Waiting To Blast Off in 2018

  Immuno-oncology therapeutics have revolutionized certain types of cancer treatments, and they are, in many ways, as close to miracle cures as we’ve seen in decades.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Teva Sees Approval at Finish Line for Anti-CGRP Migraine Treatment

  With a priority review voucher in hand, Teva is expecting the FDA to rule on its new migraine treatment fremanezumab by June.

  December 22, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  FDA Proposes Easing of Medical Device Malfunctioning Reporting

  The U.S. Food and Drug Administration on Friday said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis to cut down on repeated reviews of common problems.

  December 22, 2017

   · 

  1 min read
• JHL Biotech Proposes Voluntary Delisting from Taiwan Exchange

  The biosimilar company, which has a $419M market capitalization, operates in Taiwan and Wuhan, China.

  December 22, 2017

   · 

  1 min read
• Business

  AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board

  Prior to formally joining AbSci’s Scientific Advisory Board, Dr. Larimore advised AbSci on various aspects of biopharmaceutical process development manufacturing scale-up.

  December 22, 2017

   · 

  2 min read
• Business

  NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement

  NovaBay announces stockholder approval to issue NovaBay common stock as part of a $10.32 million financing agreement with Ch-gemstone Capital (Beijing) Co., Ltd.

  December 22, 2017

   · 

  3 min read
• Business

  gel-e Expands Board of Directors With Domain & Commercial Strategy Expert

  gel-e, a privately held, clinical-stage medical device company, announces the expansion of its Board of Directors to include industry veteran Jim Buck.

  December 22, 2017

   · 

  2 min read
• Paragon 28 Launches the Gorilla Lateral Column Plating System - the First Dedicated Plating System Designed to Address the Cuboid and Lateral Column in Cases of Charcot Deformity

  Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

  December 22, 2017

   · 

  2 min read
• Business

  MediSapiens Joins the FinnGen Project and Brings Solutions to Curation, Management and Visualization of Genetic and Clinical Data of 500.000 Finns

  MediSapiens will provide its data curation, data management, data exploration and discovery software solutions to FinnGen, and will be an active technology partner in the project.

  December 22, 2017

   · 

  4 min read